EQL Pharma publishes information memorandum
NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. EQL Pharma AB (publ) (“the Company”) today publishes an information memorandum in connection with the rights issue decided by the Company’s board of directors on the 17th of October 2018. The information memorandum is made available on the Company’s website and on Spotlight Stock Market’s,